113 related articles for article (PubMed ID: 8334128)
1. Effect of the mutation of tyrosine 713 in p93c-fes on its catalytic activity and ability to promote myeloid differentiation in K562 cells.
Fang F; Ahmad S; Lei J; Klecker RW; Trepel JB; Smithgall TE; Glazer RI
Biochemistry; 1993 Jul; 32(27):6995-7001. PubMed ID: 8334128
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
[TBL] [Abstract][Full Text] [Related]
3. Construction of a cDNA for the human c-fes protooncogene protein-tyrosine kinase and its expression in a baculovirus system.
Smithgall TE; Goswami BB; Nagashfar Z; Ahmad S; Glazer RI
Biochemistry; 1992 May; 31(20):4828-33. PubMed ID: 1591243
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of the ras GTPase-activating protein (GAP) by the p93c-fes protein-tyrosine kinase in vitro and formation of GAP-fes complexes via an SH2 domain-dependent mechanism.
Hjermstad SJ; Briggs SD; Smithgall TE
Biochemistry; 1993 Oct; 32(39):10519-25. PubMed ID: 7691175
[TBL] [Abstract][Full Text] [Related]
5. p210Bcr/Abl and p160v-Abl induce an increase in the tyrosine phosphorylation of p93c-Fes.
Ernst TJ; Slattery KE; Griffin JD
J Biol Chem; 1994 Feb; 269(8):5764-9. PubMed ID: 8119916
[TBL] [Abstract][Full Text] [Related]
6. K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation.
Yu G; Smithgall TE; Glazer RI
J Biol Chem; 1989 Jun; 264(17):10276-81. PubMed ID: 2656706
[TBL] [Abstract][Full Text] [Related]
7. Identification of the differentiation-associated p93 tyrosine protein kinase of HL-60 leukemia cells as the product of the human c-fes locus and its expression in myelomonocytic cells.
Smithgall TE; Yu G; Glazer RI
J Biol Chem; 1988 Oct; 263(29):15050-5. PubMed ID: 3170574
[TBL] [Abstract][Full Text] [Related]
8. A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells.
Cheng HY; Schiavone AP; Smithgall TE
Mol Cell Biol; 2001 Sep; 21(18):6170-80. PubMed ID: 11509660
[TBL] [Abstract][Full Text] [Related]
9. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
Rogers JA; Cheng HY; Smithgall TE
Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
[TBL] [Abstract][Full Text] [Related]
10. Autophosphorylation of the Fes tyrosine kinase. Evidence for an intermolecular mechanism involving two kinase domain tyrosine residues.
Rogers JA; Read RD; Li J; Peters KL; Smithgall TE
J Biol Chem; 1996 Jul; 271(29):17519-25. PubMed ID: 8663427
[TBL] [Abstract][Full Text] [Related]
11. The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl.
Lionberger JM; Smithgall TE
Cancer Res; 2000 Feb; 60(4):1097-103. PubMed ID: 10706130
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of c-Fes in myeloid leukemia cells.
He Y; Borellini F; Koch WH; Huang KX; Glazer RI
Biochim Biophys Acta; 1996 May; 1306(2-3):179-86. PubMed ID: 8634335
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of the c-fes proto-oncogene in adult human myeloid leukemia cells in the absence of gene amplification.
Smithgall TE; Johnston JB; Bustin M; Glazer RI
J Natl Cancer Inst; 1991 Jan; 83(1):42-6. PubMed ID: 1984516
[TBL] [Abstract][Full Text] [Related]
14. Regulation of c-Fes tyrosine kinase activity by coiled-coil and SH2 domains: analysis with Saccharomyces cerevisiae.
Takashima Y; Delfino FJ; Engen JR; Superti-Furga G; Smithgall TE
Biochemistry; 2003 Apr; 42(12):3567-74. PubMed ID: 12653561
[TBL] [Abstract][Full Text] [Related]
15. A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer.
Delfino FJ; Stevenson H; Smithgall TE
J Biol Chem; 2006 Mar; 281(13):8829-35. PubMed ID: 16455651
[TBL] [Abstract][Full Text] [Related]
16. Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines.
Jücker M; Roebroek AJ; Mautner J; Koch K; Eick D; Diehl V; Van de Ven WJ; Tesch H
Oncogene; 1992 May; 7(5):943-52. PubMed ID: 1373879
[TBL] [Abstract][Full Text] [Related]
17. Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains.
Cheng H; Rogers JA; Dunham NA; Smithgall TE
Mol Cell Biol; 1999 Dec; 19(12):8335-43. PubMed ID: 10567558
[TBL] [Abstract][Full Text] [Related]
18. Human c-FES is a nuclear tyrosine kinase.
Yates KE; Lynch MR; Wong SG; Slamon DJ; Gasson JC
Oncogene; 1995 Mar; 10(6):1239-42. PubMed ID: 7700650
[TBL] [Abstract][Full Text] [Related]
19. The c-Fes family of protein-tyrosine kinases.
Smithgall TE; Rogers JA; Peters KL; Li J; Briggs SD; Lionberger JM; Cheng H; Shibata A; Scholtz B; Schreiner S; Dunham N
Crit Rev Oncog; 1998; 9(1):43-62. PubMed ID: 9754447
[TBL] [Abstract][Full Text] [Related]
20. Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation.
Tagliafico E; Siena M; Zanocco-Marani T; Manfredini R; Tenedini E; Montanari M; Grande A; Ferrari S
Oncogene; 2003 Mar; 22(11):1712-23. PubMed ID: 12642874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
